ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 138425 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 138425; 2) Community: the network communities that were significantly associated with the response to NSC 138425; 3) Molecule: the relationships between components within communities and NSC 138425; 4) MDR: the compounds that were significantly associated with the NSC 138425.

NSC Compound Enrichment Correlation
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.00396220821750028 0.50929694
NSC 747287 Null 0.00396220821750028 0.39466245
NSC 750485 [(1H-benzimidazole-2-yl)dithio]-9H-purine 0.00396220821750028 0.22368141
NSC 80141 Null 0.00396220821750028 -0.13585185
NSC 267319 Null 0.00415749398947839 0.35356742
NSC 271967 Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) 0.00415749398947839 0.2555919
NSC 731700 1[(4-benzyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-dio late 0.00415749398947839 0.27110406
NSC 144310 4H-Thiopyran-4-one, 3,5-bis[(3,4-dimethoxyphenyl) methylene]-tetrahydro- 0.00423163567577548 0.61270819
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.00423163567577548 0.538303
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.00423163567577548 0.47495307
Total:88  Current:13    [First] [Prev] [Next] [Last]